Business Description
Virbac SA
ISIN : FR0000031577
Compare
Compare
Traded in other countries / regions
VIRP.France0NM7.UKV16.GermanyVRBCF.USA IPO Date
1989-07-27Description
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by Asia and Latin America.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.47 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 0.52 | |||||
Interest Coverage | 20.91 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.84 | |||||
Beneish M-Score | -2.29 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.1 | |||||
3-Year EBITDA Growth Rate | -1.6 | |||||
3-Year EPS without NRI Growth Rate | 9.2 | |||||
3-Year FCF Growth Rate | -13.2 | |||||
3-Year Book Growth Rate | 13.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 15.58 | |||||
Future 3-5Y Total Revenue Growth Rate | 7.76 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.31 | |||||
9-Day RSI | 48.11 | |||||
14-Day RSI | 48.23 | |||||
6-1 Month Momentum % | 0.72 | |||||
12-1 Month Momentum % | 28.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.93 | |||||
Quick Ratio | 1.08 | |||||
Cash Ratio | 0.44 | |||||
Days Inventory | 281.51 | |||||
Days Sales Outstanding | 47.75 | |||||
Days Payable | 122.77 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.39 | |||||
Dividend Payout Ratio | 0.09 | |||||
Forward Dividend Yield % | 0.39 | |||||
5-Year Yield-on-Cost % | 0.39 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 0.25 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 64.93 | |||||
Operating Margin % | 14.89 | |||||
Net Margin % | 9.73 | |||||
FCF Margin % | 4.71 | |||||
ROE % | 13.79 | |||||
ROA % | 8.64 | |||||
ROIC % | 14.44 | |||||
ROC (Joel Greenblatt) % | 37.78 | |||||
ROCE % | 18.04 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 23.78 | |||||
Forward PE Ratio | 19.57 | |||||
PE Ratio without NRI | 24.31 | |||||
Shiller PE Ratio | 39.51 | |||||
Price-to-Owner-Earnings | 26.92 | |||||
PEG Ratio | 1.77 | |||||
PS Ratio | 2.31 | |||||
PB Ratio | 3.18 | |||||
Price-to-Tangible-Book | 5.21 | |||||
Price-to-Free-Cash-Flow | 48.98 | |||||
Price-to-Operating-Cash-Flow | 24.28 | |||||
EV-to-EBIT | 15.34 | |||||
EV-to-EBITDA | 12.11 | |||||
EV-to-Revenue | 2.25 | |||||
EV-to-FCF | 47.81 | |||||
Price-to-Projected-FCF | 1.71 | |||||
Price-to-Median-PS-Value | 1.23 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.78 | |||||
Price-to-Graham-Number | 2.38 | |||||
Price-to-Net-Current-Asset-Value | 13.25 | |||||
Earnings Yield (Greenblatt) % | 6.52 | |||||
FCF Yield % | 2.05 | |||||
Forward Rate of Return (Yacktman) % | 16.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Virbac SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1,246.901 | ||
EPS (TTM) (€) | 14.38 | ||
Beta | 0.85 | ||
Volatility % | 31.63 | ||
14-Day RSI | 48.23 | ||
14-Day ATR (€) | 8.48898 | ||
20-Day SMA (€) | 342.375 | ||
12-1 Month Momentum % | 28.73 | ||
52-Week Range (€) | 239 - 377.5 | ||
Shares Outstanding (Mil) | 8.37 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Virbac SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Virbac SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Virbac SA Frequently Asked Questions
What is Virbac SA(XPAR:VIRP)'s stock price today?
The current price of XPAR:VIRP is €342.00. The 52 week high of XPAR:VIRP is €377.50 and 52 week low is €239.00.
When is next earnings date of Virbac SA(XPAR:VIRP)?
The next earnings date of Virbac SA(XPAR:VIRP) is .
Does Virbac SA(XPAR:VIRP) pay dividends? If so, how much?
The Dividend Yield %  of Virbac SA(XPAR:VIRP) is 0.39% (As of Today), Highest Dividend Payout Ratio of Virbac SA(XPAR:VIRP) was 1.93. The lowest was 0.05. And the median was 0.09. The  Forward Dividend Yield % of Virbac SA(XPAR:VIRP) is 0.39%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |